BRE96-1
Randomized Pilot Trial of Combination Versus Sequential Taxotere (T) and Doxorubicin (D) as Primary Chemotherapy for Breast Cancer
Abstracts/Posters/Presentations:
- Miller KD, McCaskill-Stevens W, Sisk J, Loesch DM, Sledge Jr G. Randomized Pilot Trial of Taxotere (T) and Doxorubicin (D) as Primary Chemotherapy for Breast Cancer: A Hoosier Oncology Group Trial BRE96-1 and Walther Cancer Institute, Indianapolis, IN. Accepted to the ASCO annual meeting May 15-18, 1999, Atlanta, GA
Manuscripts/Articles:
- Miller KD, McCaskill-Stevens W, Sisk J, Loesch DM, Monaco F, Seshadri R, Sledge Jr G. Randomized Pilot Trial of Combination Versus Sequential Taxotere (T) and Doxorubicin (D) as Primary Chemotherapy for Breast Cancer: A Hoosier Oncology Group Trial BRE96-1. Journal of Clinical Oncology 17: No. 10 (October),1999:pp3033-3037. See abstract.
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter